BUY Eris Lifesciences Limited — Prabhudas Lilladher
byPrabhudas LilladherHorizon: NA (inferred 1 year)6 Aug 2025via Institutional / Brokerage Research
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
Eris Lifesciences' Q1 profit jumps 21%, but margins come under pressure
NewsCnbc-Tv18·29 Jul · 1w ago
3 other SEBI-registered advisors have active long-term BUY calls on this stock, with 1 issued in the last 14 days
Advisor consensus · same horizon·29 Jul · 1w ago
Eris Lifesciences Limited has drawn down a working capital term loan of ₹64.40 Crores from Axis Bank Limited to meet short-term liabilities. The aggregate debt level of the company remains unchanged.
NSE · Agreements·6 Aug · today
Bajaj Housing Finance, Radico, Equitas SFB, KPIT Tech, Eris, Vinati Organics And More Q1 Review — Check Motilal Oswal's Latest Ratings, Target Prices, Upside Potential
NewsNdtv-Profit·30 Jul · 1w ago
Eris Lifesciences Limited announced the approval and recording of its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. The company also re-appointed its Cos
NSE · Outcome of Board Meeting·29 Jul · 1w ago
Eris Lifesciences Ltd announced the outcome of its board meeting held on July 29, 2026. The board approved the unaudited standalone and consolidated financial results for the quarter ended June 30, 20
BSE · Board Meeting·29 Jul · 1w ago
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.